Connect Biopharma News

Connect Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Panacea Innovation Limited(21.8%),Panacea Venture Healthcare Fund II, L.P.(21.8%), etc.

Feb 27 21:02 ET

Connect Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%), etc.

Feb 27 16:28 ET

Connect Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Panacea Innovation Limited(16.2%),Panacea Venture Healthcare Fund II, L.P.(16.2%), etc.

Feb 13 16:38 ET

Connect Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wubin Pan(12.1%),BioFortune Inc(11.2%)

Feb 13 16:32 ET

Connect Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Zheng Wei(11.7%)

Feb 13 16:29 ET

Connect Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(5.6%),Peter Kolchinsky(5.6%), etc.

Dec 20, 2023 16:30 ET

Connect Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(9.3%),Peter Kolchinsky(9.3%), etc.

Dec 14, 2023 16:30 ET

Connect Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(10.8%),Peter Kolchinsky(10.8%), etc.

Dec 4, 2023 17:20 ET

Connect Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Panacea Innovation Limited(10.9%),Panacea Venture Healthcare Fund II, L.P.(10.9%), etc.

Oct 4, 2023 17:26 ET

Connect Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Qiming Corporate GP V, Ltd(5.8%),Qiming GP V, L.P.(5.6%), etc.

Feb 14, 2023 06:27 ET

Connect Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Shanghai Minhui Enterprise Management Consulting Partnership (Limited Partnership)(9.6%),Suzhou Xiangtang Venture Investment Limited(9.6%), etc.

Feb 13, 2023 17:20 ET

Connect Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Zheng Wei(11.3%)

Feb 13, 2023 17:13 ET

Connect Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wubin Pan(11.3%),BioFortune Inc.(10.7%)

Feb 13, 2023 17:13 ET

Connect Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(0.000%),Abigail P. Johnson(0.000%)

Feb 9, 2023 09:59 ET

Connect Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Panacea Opportunity Fund I, L.P.(5.1%),Panacea Opportunity Fund I GP Company, Ltd.(5.1%), etc.

Jan 3, 2023 16:31 ET

Connect Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Zheng Wei(11.0%)

Feb 25, 2022 16:43 ET

Connect Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Wubin Pan(11.1%),BioFortune Inc.(10.8%)

Feb 25, 2022 16:42 ET

Connect Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Advantech Capital II L.P.(8.5%),Advantech Capital II Connect Partnership L.P.(8.5%), etc.

Feb 15, 2022 06:05 ET

Connect Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Qiming Corporate GP V, Ltd(5.8%),Qiming GP V, L.P.(5.6%), etc.

Feb 14, 2022 06:13 ET

Connect Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-FMR LLC(6.335%),Abigail P. Johnson(6.335%)

Feb 9, 2022 09:11 ET